These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 34769109)

  • 1. The Role of Gut Dysbiosis in Acute-on-Chronic Liver Failure.
    Kim SE; Park JW; Kim HS; Jang MK; Suk KT; Kim DJ
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The microbiota in cirrhosis and its role in hepatic decompensation.
    Trebicka J; Macnaughtan J; Schnabl B; Shawcross DL; Bajaj JS
    J Hepatol; 2021 Jul; 75 Suppl 1(Suppl 1):S67-S81. PubMed ID: 34039493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure.
    Trebicka J; Bork P; Krag A; Arumugam M
    Nat Rev Gastroenterol Hepatol; 2021 Mar; 18(3):167-180. PubMed ID: 33257833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Intestinal Microbiota Collected at Hospital Admission and Outcomes of Patients With Cirrhosis.
    Bajaj JS; Vargas HE; Reddy KR; Lai JC; O'Leary JG; Tandon P; Wong F; Mitrani R; White MB; Kelly M; Fagan A; Patil R; Sait S; Sikaroodi M; Thacker LR; Gillevet PM
    Clin Gastroenterol Hepatol; 2019 Mar; 17(4):756-765.e3. PubMed ID: 30036646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered Microbiome in Patients With Cirrhosis and Complications.
    Acharya C; Bajaj JS
    Clin Gastroenterol Hepatol; 2019 Jan; 17(2):307-321. PubMed ID: 30099098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut dysbiosis in acute-on-chronic liver failure and its predictive value for mortality.
    Chen Y; Guo J; Qian G; Fang D; Shi D; Guo L; Li L
    J Gastroenterol Hepatol; 2015 Sep; 30(9):1429-37. PubMed ID: 25711972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease.
    Woodhouse CA; Patel VC; Singanayagam A; Shawcross DL
    Aliment Pharmacol Ther; 2018 Jan; 47(2):192-202. PubMed ID: 29083037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in Gut Microbiome in Cirrhosis as Assessed by Quantitative Metagenomics: Relationship With Acute-on-Chronic Liver Failure and Prognosis.
    Solé C; Guilly S; Da Silva K; Llopis M; Le-Chatelier E; Huelin P; Carol M; Moreira R; Fabrellas N; De Prada G; Napoleone L; Graupera I; Pose E; Juanola A; Borruel N; Berland M; Toapanta D; Casellas F; Guarner F; Doré J; Solà E; Ehrlich SD; Ginès P
    Gastroenterology; 2021 Jan; 160(1):206-218.e13. PubMed ID: 32941879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of the gut-liver axis in the pathogenesis of acute-on-chronic liver failure.
    Zhang T; Sun K; Wang Y; Huang L; Lang R; Jiang W
    Eur J Gastroenterol Hepatol; 2018 Feb; 30(2):130-135. PubMed ID: 29200007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver cirrhosis and immune dysfunction.
    Hasa E; Hartmann P; Schnabl B
    Int Immunol; 2022 Sep; 34(9):455-466. PubMed ID: 35792761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota as prognosis markers for patients with HBV-related acute-on-chronic liver failure.
    Wang K; Zhang Z; Mo ZS; Yang XH; Lin BL; Peng L; Xu Y; Lei CY; Zhuang XD; Lu L; Yang RF; Chen T; Gao ZL
    Gut Microbes; 2021; 13(1):1-15. PubMed ID: 34006193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the circulating microbiome in acute-on-chronic liver failure associated with hepatitis B.
    Zhang Y; Zhao R; Shi D; Sun S; Ren H; Zhao H; Wu W; Jin L; Sheng J; Shi Y
    Liver Int; 2019 Jul; 39(7):1207-1216. PubMed ID: 30864226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial infection triggers and complicates acute-on-chronic liver failure in patients with hepatitis B virus-decompensated cirrhosis: A retrospective cohort study.
    Cao ZJ; Liu YH; Zhu CW; Yin S; Wang WJ; Tang WL; Zhao GD; Xu YM; Chen L; Zhou TH; Cai MH; Wang H; Cai W; Bao SS; Li H; Xie Q
    World J Gastroenterol; 2020 Feb; 26(6):645-656. PubMed ID: 32103873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut Microbiota and Complications of Liver Disease.
    Acharya C; Bajaj JS
    Gastroenterol Clin North Am; 2017 Mar; 46(1):155-169. PubMed ID: 28164848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiome-brain-cirrhosis axis.
    Smith ML; Wade JB; Wolstenholme J; Bajaj JS
    Hepatology; 2024 Aug; 80(2):465-485. PubMed ID: 36866864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of the Gut Microbiome in Liver Cirrhosis Treatment.
    Lee NY; Suk KT
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33379148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Only in the darkness can you see the stars: Severe alcoholic hepatitis and higher grades of acute-on-chronic liver failure.
    Philips CA; Augustine P; Padsalgi G; Ahamed R; Jose A; Rajesh S
    J Hepatol; 2019 Mar; 70(3):550-551. PubMed ID: 30470480
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute-on-chronic liver failure in patients with alcohol-related liver disease.
    Gustot T; Jalan R
    J Hepatol; 2019 Feb; 70(2):319-327. PubMed ID: 30658733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute-on-chronic liver failure in cirrhosis.
    Arroyo V; Moreau R; Kamath PS; Jalan R; Ginès P; Nevens F; Fernández J; To U; García-Tsao G; Schnabl B
    Nat Rev Dis Primers; 2016 Jun; 2():16041. PubMed ID: 27277335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbiota, cirrhosis, and the emerging oral-gut-liver axis.
    Acharya C; Sahingur SE; Bajaj JS
    JCI Insight; 2017 Oct; 2(19):. PubMed ID: 28978799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.